Friday 22 January 2016

Sun Pharma gets CCI approval to sell CNS unit to Strides Shasun

Sun Pharmaceutical Industries received order under the Competition Act, 2002 from the Competition Commission of India approving the proposed transaction.


Sun Pharmaceutical Industries Ltd has now informed BSE that the Company has, on January 21, 2016 received order under the Competition Act, 2002 from the Competition Commission of India (CCI) approving the proposed transaction.

With this approval, all necessary regulatory approvals have been obtained.

Stock Commentary:

 Sun Pharmaceuticals Industries Ltd is currently trading at Rs. 778.1, up by Rs. 4.85 or 0.63% from its previous closing of Rs. 773.25 on the BSE.

The scrip opened at Rs. 775 and has touched a high and low of Rs. 782.75 and Rs. 774.25 respectively. So far 99962(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 186095.45 crore.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.7 on 07-Apr-2015 and a 52 week low of Rs. 706.4 on 24-Nov-2015. Last one week high and low of the scrip stood at Rs. 803.4 and Rs. 762.45 respectively.

The promoters holding in the company stood at 54.71 % while Institutions and Non-Institutions held 35.62 % and 9.68 % respectively.

The stock is currently trading below its 200 DMA.

No comments:

Post a Comment